Pancreatic Cancer Research

ResearcherChinese University of Hong KongNo recent work listed

Huiyi Feng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3837-7845; OpenAlex author ID A5101805638. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

  1. LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.jcmgh.2020.06.009↗
  2. Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective. Co-author DOI 10.3748/wjg.v22.i33.7463↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yangchao Chen · 2 shared papers, 2016–2020 · strength 0.23
  2. Yinxin Zhu · 1 shared paper, 2020 · strength 0.11
  3. Chi Han Li · 1 shared paper, 2020 · strength 0.11
  4. Guolin Li · 1 shared paper, 2020 · strength 0.11
  5. Chi Hin Wong · 1 shared paper, 2020 · strength 0.11
  6. Rufu Chen · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.